Novavax’s COVID vaccine gets FDA approval
Digest more
Top News
Overview
Impacts
"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at low risk," the agency said in an article published by The New England Journal of Medicine, authored by FDA Commissioner Dr. Martin Makary and his new top vaccines official, Dr. Vinay Prasad.
Only adults 65 and older or people with another health problem that puts them at higher risk will be able to get the shots under the FDA's new framework.
The FDA finally approved Novavax's Covid-19 vaccine, but placed restrictions on it that its two competitors in the U.S. do not face